Eton Pharmaceuticals Inc (ETON)
10.95
+0.20
(+1.86%)
USD |
NASDAQ |
Nov 22, 11:08
Eton Pharmaceuticals Debt to Equity Ratio: 0.2581 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.2581 |
| June 30, 2024 | 0.346 |
| March 31, 2024 | 0.324 |
| December 31, 2023 | 0.3476 |
| September 30, 2023 | 0.3396 |
| June 30, 2023 | 0.3643 |
| March 31, 2023 | 0.5734 |
| December 31, 2022 | 0.4907 |
| September 30, 2022 | 0.5711 |
| June 30, 2022 | 0.48 |
| March 31, 2022 | 0.4731 |
| December 31, 2021 | 0.3789 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.4241 |
| June 30, 2021 | 0.3258 |
| March 31, 2021 | 0.3284 |
| December 31, 2020 | 0.4497 |
| September 30, 2020 | 5.048 |
| June 30, 2020 | 0.7037 |
| March 31, 2020 | 0.4303 |
| December 31, 2019 | 0.4303 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2581
Minimum
Sep 2024
5.048
Maximum
Sep 2020
0.6544
Average
0.4272
Median
Debt to Equity Ratio Benchmarks
| Biomarin Pharmaceutical Inc | 0.1098 |
| Integra Lifesciences Holdings Corp | 1.187 |
| Elutia Inc | -0.5627 |
| Immuneering Corp | -- |
| Journey Medical Corp | 1.811 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 35.84M |
| Total Liabilities (Quarterly) | 19.86M |
| Shareholders Equity (Quarterly) | 15.98M |
| Current Ratio | 1.508 |
| Net Debt Paydown Yield | 0.25% |